13.09.2011 • NewsDSMRoyal DSMRob van Leen

DSM to sell Personalized Nutrition to Viocare

Royal DSM, the global Life Sciences and Materials Sciences company, today announces that it has sold DSM Personalized Nutrition to Viocare. DSM will remain involved in the business as a minority shareholder in Viocare through DSM Venturing. Financial details of the transaction will not be disclosed.

Personalized Nutrition was an Emerging Business Area in the Innovation Center. As announced in September 2010, the focus was moved to other EBA's and Personalized Nutrition activities were to be partnered, exited or transferred to other parts of DSM. DSM Personalized Nutrition's corporate wellness business will become part of Viocare's operations, and a representative of DSM Venturing will join Viocare's Board of Directors.

Rob van Leen, Chief Innovation Officer of DSM, commented: "Our investment in Viocare in conjunction with the divestment of our corporate wellness business allows Viocare to further expand and mature this business, while concurrently enabling Viocare to continue to advance its leadership position as a supplier of scientifically validated software tools for the nutrition and wellness community."

Rick Weiss, Founder and President of Viocare, said: "This investment further validates our vision that by deploying technology solutions that personalize diet and fitness recommendations based upon the latest scientifically validated advancements in nutrition and behaviour change we can make a real difference in the long term health and wellness of the global population."

 

Virtual Event

DIGITALIZATION IN THE CHEMICAL INDUSTRY

DIGITALIZATION IN THE CHEMICAL INDUSTRY

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.